Histological re-evaluation of 26 patients who, according to the Finnish Cancer Registry, were diagnosed with pancreatic ductal adenocarcinoma between 1990 and 1996 and survived for at least 5 years
| n | (%) | Follow up data | |
|---|---|---|---|
| DCR, dead from cancer recurrence; DOD, dead from other disease; AWC, alive without cancer. | |||
| Verified ductal adenocarcinoma | 10 | 38 | |
| Stage IA (T1 N0 M0) | 1 | 4 | 1 DCR (5.48 y) |
| Stage IB (T2 N0 M0) | 5 | 19 | 3 DCR (5.10–5.86 y), 1 DOD (5.06 y), 1 AWC (13.4 y) |
| Stage IIA (T3 N0 M0) | 2 | 8 | 1 DCR (5.31 y), 1 DOD (6.20 y) |
| Stage IIB (T2-3N1M0) | 2 | 8 | 2 DCR (5.12–5.59 y) |
| Wrong diagnosis | 14 | 54 | |
| Intraductal papillary-mucinous neoplasm | 2 | 8 | |
| Solid pseudopapillary neoplasm | 1 | 4 | |
| Pancreatitis | 2 | 8 | |
| Serous cystadenoma | 1 | 4 | |
| Common bile duct carcinoma | 1 | 4 | |
| Ampullary/periampullary carcinoma | 7 | 27 | |
| Histological material not available | 2 | 8 | |
| Total | 26 | 100 | |